Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel DiseasesErwin Dreesen, Séverine Vermeire, Bram Verstockt et al.|Clinical Gastroenterology and Hepatology|2018Cited by 158
Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testingBram Verstockt, Marc Ferrante, Ann Gils et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 74
Assessing global sustainability performance, imbalance, and coordination over space and timeZhenci Xu, Jianguo Liu, Zhongbin Li et al.|Nature Communications|2025Cited by 18